|
Carfilzomib
A next generation proteasome inhibitor
Product Overview
Product Name: Carfilzomib
Alternate Name/Synonyms: (S)-4-methyl-N-((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide; PR-171
Description: Carfilzomib (PR-171) is a next generation, irreversible and selective inhibitor of the chymotrypsin-like activity of the proteasome. It displays potent antineoplastic activity.
Peptide Sequence: N/A
Appearance: Crystalline solid
Formulation: N/A
CAS Number: 868540-17-4
Molecular Formula: C40H57N5O7
Molecular Weight: 719.91
Purity: ≥98% by HPLC
Solubility:DMSO (~50 mg/ml)
Storage Temp.: -20 ̊C
Shipping Conditions: gel pack
Handling: Protect from light and moisture
SMILES: CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4
InChi: InChI=1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49)/t31-,32-,33-,34-,40+/m0/s1
InChi Key: BLMPQMFVWMYDKT-NZTKNTHTSA-N
PubChem CID: 11556711
MDL Number: N/A
USAGE: For Research Use Only! Not For Use in Humans. |